Amgen SVP Unloads $1.35M of Stock Amid Bullish Outlook

Rachna Khosla, Senior Vice President of Business Development at Amgen Inc. (), sold approximately $1.35 million worth of company stock in mid-August through two transactions. The sales occurred on August 11 and 13, with prices ranging from $412.57 to $416.43 per share.

The stock trades at $417.84, just 1% below its 52-week high of $421.79, following a strong 49% gain over the past year. Khosla sold 2,000 shares on August 11 and acquired 1,252 shares through option exercise on August 13, selling them all at $416.43 per share.

The total value of the stock sold is approximately $1.35 million. Following these transactions, Khosla directly holds 6,404 shares of Amgen common stock. According to InvestingPro analysis, Amgen appears undervalued at current levels, with a 'GREAT' financial health score.